Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2022

  1. Management and prognosis of HIV-associated pulmonary arterial hypertension: 20 Years of evidence from the REHAP registry

    Journal of Internal Medicine, Vol. 292, Núm. 1, pp. 116-126

2016

  1. Vascular effects of sildenafil in patients with pulmonary fibrosis and pulmonary hypertension: An ex vivo/in vitro study

    European Respiratory Journal, Vol. 47, Núm. 6, pp. 1737-1749

2015

  1. Role of circulating miRNAs as biomarkers in idiopathic pulmonary arterial hypertension: Possible relevance of miR-23a

    Oxidative Medicine and Cellular Longevity, Vol. 2015

2012

  1. Bosentan inhibits cigarette smoke-induced endothelin receptor expression in pulmonary arteries

    European Respiratory Journal, Vol. 39, Núm. 4, pp. 927-938

  2. Neutrophil activation in severe, early-onset COPD patients versus healthy non-smoker subjects in vitro: Effects of antioxidant therapy

    Respiration, Vol. 83, Núm. 2, pp. 147-158

  3. Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition

    Thorax, Vol. 67, Núm. 2, pp. 147-156

2010

  1. Cigarette smoke exposure up-regulates endothelin receptor B in human pulmonary artery endothelial cells: Molecular and functional consequences

    British Journal of Pharmacology, Vol. 161, Núm. 7, pp. 1599-1615

  2. Cigarette smoke-induced pulmonary endothelial dysfunction is partially suppressed by sildenafil

    European Journal of Pharmaceutical Sciences, Vol. 39, Núm. 5, pp. 363-372

  3. Direct effect of cigarette smoke on human pulmonary artery tension

    Pulmonary Pharmacology and Therapeutics, Vol. 23, Núm. 3, pp. 222-228